communiqu\u00e9 de presse du 10 juillet 2020<\/a>. Nicox a re\u00e7u le prix de la cession, soit 5 millions d\u2019euros.<\/p>\nMichele Garufi, Pr\u00e9sident Directeur G\u00e9n\u00e9ral de Nicox<\/strong>, a d\u00e9clar\u00e9, \u201cNous sommes satisfaits de la finalisation de cette transaction qui renforce la position de tr\u00e9sorerie de la Soci\u00e9t\u00e9.<\/em>\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce aujourd\u2019hui la finalisation de la cession du solde de sa participation dans VISUfarma, soci\u00e9t\u00e9 pharmaceutique pan-europ\u00e9enne sp\u00e9cialis\u00e9e en ophtalmologie, comme pr\u00e9vu et annonc\u00e9 dans son communiqu\u00e9 de presse du 10 juillet 2020. Nicox a re\u00e7u le prix de […]<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[32,16],"tags":[],"class_list":["post-7710","post","type-post","status-publish","format-standard","hentry","category-actualites","category-actualites-et-media"],"acf":[],"yoast_head":"\n
Nicox re\u00e7oit 5 millions d\u2019euros suite \u00e0 la finalisation de la cession de sa participation dans VISUfarma - Nicox<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.nicox.com\/fr\/nicox-recoit-5-millions-deuros-suite-a-la-finalisation-de-la-cession-de-sa-participation-dans-visufarma-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nicox re\u00e7oit 5 millions d\u2019euros suite \u00e0 la finalisation de la cession de sa participation dans VISUfarma - Nicox\" \/>\n<meta property=\"og:description\" content=\"Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce aujourd\u2019hui la finalisation de la cession du solde de sa participation dans VISUfarma, soci\u00e9t\u00e9 pharmaceutique pan-europ\u00e9enne sp\u00e9cialis\u00e9e en ophtalmologie, comme pr\u00e9vu et annonc\u00e9 dans son communiqu\u00e9 de presse du 10 juillet 2020. Nicox a re\u00e7u le prix de […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.nicox.com\/fr\/nicox-recoit-5-millions-deuros-suite-a-la-finalisation-de-la-cession-de-sa-participation-dans-visufarma-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Nicox\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-31T05:34:42+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-recoit-5-millions-deuros-suite-a-la-finalisation-de-la-cession-de-sa-participation-dans-visufarma-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-recoit-5-millions-deuros-suite-a-la-finalisation-de-la-cession-de-sa-participation-dans-visufarma-2\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Nicox re\u00e7oit 5 millions d\u2019euros suite \u00e0 la finalisation de la cession de sa participation dans VISUfarma\",\"datePublished\":\"2020-07-31T05:34:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-recoit-5-millions-deuros-suite-a-la-finalisation-de-la-cession-de-sa-participation-dans-visufarma-2\\\/\"},\"wordCount\":119,\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"articleSection\":[\"Actualit\u00e9s\",\"Actualit\u00e9s et M\u00e9dia\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-recoit-5-millions-deuros-suite-a-la-finalisation-de-la-cession-de-sa-participation-dans-visufarma-2\\\/\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-recoit-5-millions-deuros-suite-a-la-finalisation-de-la-cession-de-sa-participation-dans-visufarma-2\\\/\",\"name\":\"Nicox re\u00e7oit 5 millions d\u2019euros suite \u00e0 la finalisation de la cession de sa participation dans VISUfarma - Nicox\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\"},\"datePublished\":\"2020-07-31T05:34:42+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-recoit-5-millions-deuros-suite-a-la-finalisation-de-la-cession-de-sa-participation-dans-visufarma-2\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"name\":\"Nicox\",\"description\":\"Visible Science\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\",\"name\":\"Nicox\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Nicox\"},\"image\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nicox re\u00e7oit 5 millions d\u2019euros suite \u00e0 la finalisation de la cession de sa participation dans VISUfarma - Nicox","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.nicox.com\/fr\/nicox-recoit-5-millions-deuros-suite-a-la-finalisation-de-la-cession-de-sa-participation-dans-visufarma-2\/","og_locale":"fr_FR","og_type":"article","og_title":"Nicox re\u00e7oit 5 millions d\u2019euros suite \u00e0 la finalisation de la cession de sa participation dans VISUfarma - Nicox","og_description":"Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce aujourd\u2019hui la finalisation de la cession du solde de sa participation dans VISUfarma, soci\u00e9t\u00e9 pharmaceutique pan-europ\u00e9enne sp\u00e9cialis\u00e9e en ophtalmologie, comme pr\u00e9vu et annonc\u00e9 dans son communiqu\u00e9 de presse du 10 juillet 2020. Nicox a re\u00e7u le prix de […]","og_url":"https:\/\/www.nicox.com\/fr\/nicox-recoit-5-millions-deuros-suite-a-la-finalisation-de-la-cession-de-sa-participation-dans-visufarma-2\/","og_site_name":"Nicox","article_published_time":"2020-07-31T05:34:42+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.nicox.com\/fr\/nicox-recoit-5-millions-deuros-suite-a-la-finalisation-de-la-cession-de-sa-participation-dans-visufarma-2\/#article","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/nicox-recoit-5-millions-deuros-suite-a-la-finalisation-de-la-cession-de-sa-participation-dans-visufarma-2\/"},"author":{"name":"","@id":""},"headline":"Nicox re\u00e7oit 5 millions d\u2019euros suite \u00e0 la finalisation de la cession de sa participation dans VISUfarma","datePublished":"2020-07-31T05:34:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.nicox.com\/fr\/nicox-recoit-5-millions-deuros-suite-a-la-finalisation-de-la-cession-de-sa-participation-dans-visufarma-2\/"},"wordCount":119,"publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"articleSection":["Actualit\u00e9s","Actualit\u00e9s et M\u00e9dia"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.nicox.com\/fr\/nicox-recoit-5-millions-deuros-suite-a-la-finalisation-de-la-cession-de-sa-participation-dans-visufarma-2\/","url":"https:\/\/www.nicox.com\/fr\/nicox-recoit-5-millions-deuros-suite-a-la-finalisation-de-la-cession-de-sa-participation-dans-visufarma-2\/","name":"Nicox re\u00e7oit 5 millions d\u2019euros suite \u00e0 la finalisation de la cession de sa participation dans VISUfarma - Nicox","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/#website"},"datePublished":"2020-07-31T05:34:42+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.nicox.com\/fr\/nicox-recoit-5-millions-deuros-suite-a-la-finalisation-de-la-cession-de-sa-participation-dans-visufarma-2\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.nicox.com\/fr\/#website","url":"https:\/\/www.nicox.com\/fr\/","name":"Nicox","description":"Visible Science","publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.nicox.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.nicox.com\/fr\/#organization","name":"Nicox","url":"https:\/\/www.nicox.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Nicox"},"image":{"@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":""}]}},"_links":{"self":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/7710","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/comments?post=7710"}],"version-history":[{"count":0,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/7710\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/media?parent=7710"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/categories?post=7710"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/tags?post=7710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}